Lipid profiles and risk of gestational diabetes mellitus in women with isolated TPOAb positivity during early pregnancy
Open Access
- 19 May 2026
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Isolated thyroid peroxidative antibody (TPOAb) positivity has been linked to adverse pregnancy outcomes including gestational diabetes mellitus (GDM). Elevated lipids are reported as pivotal risk factors. Current researches indicated 75 g oral glucose tolerance test (OGTT) in early pregnancy has limited predictive ability for GDM. The lipid profiles in isolated TPOAb positive pregnant women and their correlation with GDM were unclear. To delineate the specific lipid profile characteristics in pregnant women with isolated TPOAb positivity and to identify potential lipid biomarkers for early prediction of GDM. Euthyroid pregnant women were enrolled in the first trimester and underwent OGTT in the second trimester. Participants were divided into four groups based on TPOAb status and OGTT results. Untargeted liquid chromatography-mass spectrometry (LC-MS) was used to identify lipid molecules. Of 88 women, 43.5% (20/46) with TPOAb positivity and 35.7% (15/42) without were diagnosed with GDM. Low-density lipoprotein (LDL) levels were positively associated with GDM risk in TPOAb positive women. LC-MS analysis identified 13 different lipid molecules significantly correlated with OGTT results. A nomogram was constructed to predict the occurrence of GDM. Elevated first-trimester LDL levels are associated with increased GDM risk in isolated TPOAb-positive women. Furthermore, PC (20:0/16:0) and TG (16:0/16:0/18:1), combined with TSH and TPOAb titers, are potential biomarkers for early prediction of GDM in this specific population.Keywords
Funding Information
- the Project of diagnosis and treatment for key clinical disease in Suzhou (LCZX202009)
- the project of development of Suzhou Medical Key disciplines (SZXK202107)
This publication has 42 references indexed in Scilit:
- Postpartum defects in inflammatory response after gestational diabetes precede progression to type 2 diabetes: a nested case-control study within the SWIFT studyMetabolism, 2023
- BMI and lipidomic biomarkers with risk of gestational diabetes in pregnant womenObesity, 2022
- Evaluation of Perinatal and Neonatal Outcomes in Pregnant Women with Thyroid Autoantibody Positivity (Anti-thyroglobulin and Anti-thyroid Peroxidase) Due to ThyroiditisSN Comprehensive Clinical Medicine, 2022
- Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progressionJournal of Genetics and Genomics, 2020
- Early pregnancy biochemical markers of placentation for screening of gestational diabetes mellitus (GDM)Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019
- Plasma lipidome patterns associated with cardiovascular risk in the PREDIMED trial: A case-cohort studyInternational Journal of Cardiology, 2018
- Thyroid disease in pregnancy: new insights in diagnosis and clinical managementNature Reviews Endocrinology, 2017
- Maternal TSH level and TPOAb status in early pregnancy and their relationship to the risk of gestational diabetes mellitusEndocrine, 2016
- Ceramides – Lipotoxic Inducers of Metabolic DisordersTrends in Endocrinology & Metabolism, 2015
- Why do anti-inflammatory therapies fail to improve insulin sensitivity?Acta Pharmacologica Sinica, 2011